Nymox Pharmaceutical Corporation (NYMX)
Create an Alert
5.35
+0.14 +2.69%
NASDAQ
Jun 18, 8:00PM
BATS Real time
Currency in USD
Nymox Pharmaceutical Corporation Shareholders Equity:
-7.845M for Dec. 31, 2012Nymox Pharmaceutical Corporation Historical Shareholders Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -7.845M |
| Sept. 30, 2012 | -8.136M |
| June 30, 2012 | -8.077M |
| March 31, 2012 | -7.384M |
| Dec. 31, 2011 | -5.598M |
| Sept. 30, 2011 | -5.900M |
| June 30, 2011 | -5.514M |
| March 31, 2011 | -3.702M |
| Dec. 31, 2010 | -2.855M |
| Sept. 30, 2010 | -1.820M |
| June 30, 2010 | -1.652M |
| March 31, 2010 | -1.006M |
| Dec. 31, 2009 | -1.452M |
| Sept. 30, 2009 | -0.7307M |
| June 30, 2009 | -1.097M |
| March 31, 2009 | -1.242M |
| Dec. 31, 2008 | -1.307M |
| Sept. 30, 2008 | 1.931M |
| June 30, 2008 | 1.896M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Shareholders' Equity
Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
Learn More
NYMX Shareholders Equity Benchmarks
| Companies | |
|---|---|
| Anika Therapeutics | 112.83M |
| Anacor Pharmaceuticals | 4.811M |
| Repligen Corporation | 87.41M |
NYMX Shareholders Equity Rankings
| Overall |
43rd percentile 9450 of 16773 |
| Sector |
34th percentile 923 of 1408 in Healthcare |
| Industry |
31st percentile 311 of 453 in Biotechnology |
NYMX Shareholders Equity Range, Past 5 Years
| Minimum | -8.136M | Sep 2012 |
| Maximum | 1.931M | Sep 2008 |
| Average | -3.236M |
